Skip to main content
logo
C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
3.490
+0.010 (0.29%)
Aug 3, 2026, 10:26 AM EDT - Market open

C4 Therapeutics Revenue

In the year 2025, C4 Therapeutics had annual revenue of $35.95M with 1.02% growth. C4 Therapeutics had revenue of $6.15M in the quarter ending March 31, 2026, with 18.83% growth.

Revenue (ttm)
$35.95M
Revenue Growth
+32.15%
P/S Ratio
11.04
Revenue / Employee
$335,202
Employees
104
Market Cap
385.88M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202535.95M363.00K1.02%
Dec 31, 202435.58M4.49M14.43%
Dec 31, 202231.10M-14.69M-32.08%
Dec 31, 202145.79M12.59M37.93%
Dec 31, 202033.20M11.81M55.25%
Dec 31, 201921.38M2.02M10.42%
Dec 31, 201819.36M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Puma Biotechnology227.18M
Century Therapeutics109.16M
Sutro Biopharma99.61M
Enanta Pharmaceuticals69.21M
Editas Medicine38.69M
vTv Therapeutics36.84M
Scribe Therapeutics36.28M
Evommune10.00M
Revenue Rankings

CCCC News

More News